These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36306457)

  • 21. Recurrent cerebrovascular events in patients after percutaneous closure of patent foramen ovale.
    Karagianni A; Mandalenakis Z; Dellborg M; Mirzada N; Johansson MC; Eriksson P
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104860. PubMed ID: 32430239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO).
    Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Figulla HR
    Clin Res Cardiol; 2008 Dec; 97(12):872-7. PubMed ID: 18696022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors and clinical outcomes of residual shunt in patients undergoing percutaneous transcatheter closure of patent foramen ovale.
    Zajarias A; Thanigaraj S; Lasala J; Perez J
    J Invasive Cardiol; 2006 Nov; 18(11):533-7. PubMed ID: 17090816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt.
    Jesurum JT; Fuller CJ; Kim CJ; Krabill KA; Spencer MP; Olsen JV; Likosky WH; Reisman M
    Am J Cardiol; 2008 Oct; 102(7):916-20. PubMed ID: 18805122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk mitigation in divers with persistent (patent) foramen ovale.
    Wilmshurst P
    Diving Hyperb Med; 2019 Jun; 49(2):77-78. PubMed ID: 31177512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Performance of the New Gore Septal Occluder in Patent Foramen Ovale Closure: A Single-Center Experience.
    Sganzerla P; Rondi M; Pavone A; Aiolfi E; Facchinetti A; Funaro A; Negrini P
    J Invasive Cardiol; 2015 Sep; 27(9):430-4. PubMed ID: 26332878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Moderate/Large Residual Shunt After PFO Closure Justifiable for a Patient with a Prior History of Cryptogenic Stroke and Transient Ischemic Attack?
    Melillo F; Popusoi G; Frecentese F; Miano V; Santoro A; Tesorio T; Onorato EM
    Int Heart J; 2024; 65(1):146-151. PubMed ID: 38296568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of High-Risk Patent Foramen Ovale Associated With Cryptogenic Stroke: Development of a Scoring System.
    Nakayama R; Takaya Y; Akagi T; Watanabe N; Ikeda M; Nakagawa K; Toh N; Ito H
    J Am Soc Echocardiogr; 2019 Jul; 32(7):811-816. PubMed ID: 31130417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saline contrast echocardiography for the detection of patent foramen ovale in hypoxia: a validation study using intracardiac echocardiography.
    Fenster BE; Curran-Everett D; Freeman AM; Weinberger HD; Kern Buckner J; Carroll JD
    Echocardiography; 2014 Apr; 31(4):420-7. PubMed ID: 24138568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up.
    Diaz T; Cubeddu RJ; Rengifo-Moreno PA; Cruz-Gonzalez I; Solis-Martin J; Buonanno FS; Inglessis I; Palacios IF
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):145-50. PubMed ID: 20578100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.
    Fischer D; Haentjes J; Klein G; Schieffer B; Drexler H; Meyer GP; Schaefer A
    J Interv Cardiol; 2011 Feb; 24(1):85-91. PubMed ID: 20735710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
    Mas JL; Derumeaux G; Guillon B; Massardier E; Hosseini H; Mechtouff L; Arquizan C; Béjot Y; Vuillier F; Detante O; Guidoux C; Canaple S; Vaduva C; Dequatre-Ponchelle N; Sibon I; Garnier P; Ferrier A; Timsit S; Robinet-Borgomano E; Sablot D; Lacour JC; Zuber M; Favrole P; Pinel JF; Apoil M; Reiner P; Lefebvre C; Guérin P; Piot C; Rossi R; Dubois-Randé JL; Eicher JC; Meneveau N; Lusson JR; Bertrand B; Schleich JM; Godart F; Thambo JB; Leborgne L; Michel P; Pierard L; Turc G; Barthelet M; Charles-Nelson A; Weimar C; Moulin T; Juliard JM; Chatellier G;
    N Engl J Med; 2017 Sep; 377(11):1011-1021. PubMed ID: 28902593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale.
    Turc G; Lee JY; Brochet E; Kim JS; Song JK; Mas JL;
    J Am Coll Cardiol; 2020 May; 75(18):2312-2320. PubMed ID: 32381162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter closure of patent foramen ovale: Current evidence and future perspectives.
    Akagi T
    J Cardiol; 2021 Jan; 77(1):3-9. PubMed ID: 33144025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology.
    Mas JL; Derex L; Guérin P; Guillon B; Habib G; Juliard JM; Marijon E; Massardier E; Meneveau N; Vuillier F
    Arch Cardiovasc Dis; 2019; 112(8-9):532-542. PubMed ID: 31378692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism.
    Wintzer-Wehekind J; Alperi A; Houde C; Côté JM; Asmarats L; Côté M; Rodés-Cabau J
    J Am Coll Cardiol; 2019 Jan; 73(3):278-287. PubMed ID: 30678757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
    Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
    BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise treadmill saline contrast echocardiography for the detection of patent foramen ovale in hypoxia.
    Fenster BE; Freeman AM; Silveira L; Buckner JK; Curran-Everett D; Carroll JD
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1537-43. PubMed ID: 26231342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
    Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP
    JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Residual Shunt after Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke: Serial Bubble Contrast Transesophageal Echocardiography Data.
    Moon J; Kim M; Oh PC; Shin DH; Park HM; Jo YY; Lee JS; Kang WC
    J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):347-353. PubMed ID: 30396838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.